Hershea Vance

Hershea Vance supports the National Institute of Allergy and Infectious Diseases (NIAID) in executing critical procurement strategies aligned with the agency’s mission to advance biomedical research for infectious, immunologic, and allergic disease threats. Though their formal title is not publicly designated, their role centers on managing complex acquisitions for high-containment laboratory infrastructure, diagnostic instrumentation, and pharmaceutical preparation systems essential to public health preparedness. They oversee contracts for specialized analytical equipment, biosafety-grade testing services, and precision maintenance of high-risk research environments, ensuring compliance with federal acquisition regulations and scientific operational requirements. Vance maintains a focused partnership with Quality Biological, Inc., a leading provider of biological reference materials and viral reagents, alongside GENOMIC LABS LTD, which delivers advanced genomic analysis capabilities. These relationships reflect a preference for specialized, technically vetted vendors with proven expertise in biosafety-compliant supply chains and research-grade reagent production. Contracting patterns indicate a reliance on established, niche suppliers rather than broad-market vendors, emphasizing reliability, regulatory adherence, and scientific specificity over volume or cost-efficiency. There is no reliance on socioeconomic set-asides; all procurements are conducted under full and open competition, reflecting a mission-driven prioritization of technical capability and readiness over socioeconomic criteria. This approach underscores NIAID’s urgency in securing mission-critical capabilities without procedural delays. Vance’s procurement portfolio is dominated by NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and 811210 (Electronic and Precision Equipment Repair and Maintenance), indicating deep engagement with high-end instrumentation such as PCR platforms, flow cytometers, and biosafety cabinet systems. Additional activity in 325412 (Pharmaceutical Preparation Manufacturing) and 541380 (Testing Laboratories and Services) highlights expertise in procuring GMP-compliant biologics and certified testing services for pathogen characterization. Their work is grounded in the technical demands of BSL-3/4 research environments and the rapid deployment of medical countermeasures.